Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in COPD
NCT01748279Phase 4Completed
- Sponsor
- Medical University of Białystok
- Start
- Dec 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Change in CD45+ cells expression at 12 weeks and Change in gene expression at 12 weeks. Started Dec 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01748279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748279.